Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Parodis

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
Plos One|June 24, 2016
Antiphospholipid Antibodies in Lupus NephritisIoannis Parodis, Laurent Arnaud, Jakob Gerhardsson, et al.
Plos One|February 12, 2019
Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritisIoannis Parodis, Huihua Ding, Agneta Zickert, et al.
Lupus Science & Medicine|January 30, 2015
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapyIoannis Parodis, Agneta Zickert, Birgitta Sundelin, et al.
Autoimmunity Reviews|February 5, 2023
COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosusNefeli Giannopoulou, Latika Gupta, Laura Andreoli, et al.
Autoimmunity Reviews|April 9, 2019
G-CSF-induced aortitis: Two cases and review of the literatureIoannis Parodis, Lara Dani, Antonella Notarnicola, et al.
Journal of Clinical Medicine|June 14, 2020
Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus ErythematosusAlvaro Gomez, Sofia Soukka, Petter Johansson, et al.
Rheumatology Advances in Practice|April 9, 2024
Lifestyle interventions in the management of systemic sclerosis: a systematic review of the literatureIoannis Parodis, Alexander Tsoi, Alvaro Gomez, et al.
Rheumatology (Oxford, England)|October 16, 2024
Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumabIoannis Parodis, Julius Lindblom, Alexander Tsoi, et al.
Expert Opinion on Biological Therapy|July 1, 2018
Smoking reduces the efficacy of belimumab in mucocutaneous lupusIoannis Parodis, Alvaro Gomez, Martina Frodlund, et al.
The Lancet. Rheumatology|January 17, 2024
Definitions of remission in systemic lupus erythematosus: a post-hoc analysis of two randomised clinical trialsIoannis Parodis, Sharzad Emamikia, Alvaro Gomez, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Plos One|June 24, 2016
Antiphospholipid Antibodies in Lupus NephritisIoannis Parodis, Laurent Arnaud, Jakob Gerhardsson, et al.
Plos One|February 12, 2019
Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritisIoannis Parodis, Huihua Ding, Agneta Zickert, et al.
Lupus Science & Medicine|January 30, 2015
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapyIoannis Parodis, Agneta Zickert, Birgitta Sundelin, et al.
Autoimmunity Reviews|February 5, 2023
COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosusNefeli Giannopoulou, Latika Gupta, Laura Andreoli, et al.
Autoimmunity Reviews|April 9, 2019
G-CSF-induced aortitis: Two cases and review of the literatureIoannis Parodis, Lara Dani, Antonella Notarnicola, et al.
Journal of Clinical Medicine|June 14, 2020
Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus ErythematosusAlvaro Gomez, Sofia Soukka, Petter Johansson, et al.
Rheumatology Advances in Practice|April 9, 2024
Lifestyle interventions in the management of systemic sclerosis: a systematic review of the literatureIoannis Parodis, Alexander Tsoi, Alvaro Gomez, et al.
Rheumatology (Oxford, England)|October 16, 2024
Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumabIoannis Parodis, Julius Lindblom, Alexander Tsoi, et al.
Expert Opinion on Biological Therapy|July 1, 2018
Smoking reduces the efficacy of belimumab in mucocutaneous lupusIoannis Parodis, Alvaro Gomez, Martina Frodlund, et al.
The Lancet. Rheumatology|January 17, 2024
Definitions of remission in systemic lupus erythematosus: a post-hoc analysis of two randomised clinical trialsIoannis Parodis, Sharzad Emamikia, Alvaro Gomez, et al.
Pageof 19